Company Description
Todos Medical Ltd. is an in vitro diagnostics company. It is focused on the development of novel blood tests for the early detection of cancer and Alzheimer's disease, and the distribution of comprehensive solutions for COVID-19 screening. It is also involved in the activities of breast cancer test,...
Todos Medical Ltd. is an in vitro diagnostics company. It is focused on the development of novel blood tests for the early detection of cancer and Alzheimer's disease, and the distribution of comprehensive solutions for COVID-19 screening. It is also involved in the activities of breast cancer test, such as TM-B1 and TM-B2. The company was founded by Rami Zigdon and Udi Zelig on April 22, 2010 and is headquartered in Tel Aviv, Israel.
Valuation
Price to Sales Ratio
3.25
Enterprise Value to EBITDA
-3.85
Enterprise Value to Sales
3.05
Total Debt to Enterprise Value
0.45
Efficiency
Revenue/Employee
531,739.00
Income Per Employee
-1,883,217.00
Receivables Turnover
8.35
Total Asset Turnover
1.16
Liquidity
Current Ratio
0.53
Quick Ratio
0.35
Cash Ratio
0.02
Profitability
Gross Margin
35.60
Operating Margin
-75.93
Pretax Margin
-340.61
Net Margin
-354.16
Return on Assets
-410.09
Return on Total Capital
-232.97
Return on Invested Capital
-2,915.79
Capital Structure
Total Debt to Total Capital
421.11
Total Debt to Total Assets
210.07
Long-Term Debt to Total Capital
394.28
Officers and Executives
| Name | Age | Officer Since | Title |
|---|---|---|---|
| Dr. Herman Weiss | 50 | 2017 | Chairman |
| Mr. Gerald E. Commissiong | 38 | 2020 | President, Chief Executive Officer & Director |
| Mr. Chris Gross | - | 2020 | Vice President-Sales Operations |
| Mr. Daniel Hirsch | 52 | - | Chief Financial Officer & Director |
| Dr. Elise Brownell | - | 2020 | Vice President-Research & Development |
Insider Actions
| 08/24/2022 |
Amarantus Bioscience Holdings, Inc. CEO and Director; Director |
1,000,000 | Acquisition at $0.03 per share. | 30,000 |
| 06/30/2021 |
Amarantus Bioscience Holdings, Inc. CEO and Director; Director |
1,051,480 | Acquisition at $0.03 per share. | 31,544 |
| 04/05/2021 |
Strategic Investment Holdings LLC |
1,724,139 | Disposition at $0.08 per share. | 137,931 |
| 04/05/2021 |
Strategic Investment Holdings LLC |
1,149,425 | Disposition at $0.08 per share. | 91,954 |
| 04/01/2021 |
Strategic Investment Holdings LLC |
98,300 | Disposition at $0.06 per share. | 5,898 |
| 04/01/2021 |
Strategic Investment Holdings LLC |
100,000 | Disposition at $0.06 per share. | 6,000 |
| 04/01/2021 |
Strategic Investment Holdings LLC |
100,000 | Disposition at $0.06 per share. | 6,000 |
| 04/01/2021 |
Strategic Investment Holdings LLC |
150,000 | Disposition at $0.05 per share. | 7,500 |
| 03/31/2021 |
Strategic Investment Holdings LLC |
100,000 | Disposition at $0.05 per share. | 5,000 |
| 03/31/2021 |
Strategic Investment Holdings LLC |
150,000 | Disposition at $0.05 per share. | 7,500 |
| 03/31/2021 |
Strategic Investment Holdings LLC |
100,000 | Disposition at $0.05 per share. | 5,000 |
| 07/07/2020 |
Strategic Investment Holdings LLC |
18,608,113 | Acquisition at $0.08 per share. | 1,488,649 |
| 04/01/2020 |
Strategic Investment Holdings LLC |
13,008,976 | Acquisition at $0.08 per share. | 1,040,718 |
| 01/21/2020 |
Strategic Investment Holdings LLC |
17,091,096 | Acquisition at $0.06 per share. | 1,025,465 |
MarketWatch News on TOMDF
No News currently available for TOMDF
Other News on TOMDF
-
- Edgar Online - (EDG = 10Q, 10K)
-
Todos launches monkeypox PCR test in US
- Seeking Alpha
-
Todos inks 2 contracts for PCR-based monkeypox testing services
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Merck's Plan B Percolates After Pfizer Announces Dominance
- Seeking Alpha
-
CFOs Plump Salaries, Perks to Land Elusive New Employees
- The Wall Street Journal Interactive Edition
-
Todos Medical re-evaluates Tollovir COVID-19 trial designs
- Seeking Alpha
-
Biogen Controversy And The Spillover Effect: Actionable Insights
- Seeking Alpha
-
Merck Desperate To Get Back In Coronavirus Race, With A Pill
- Seeking Alpha
- Loading more headlines...
